Up a level |
Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao ORCID: 0000-0002-5489-6450, Reynolds, Helen ORCID: 0000-0001-7443-4520, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan et al (show 18 more authors)
(2022)
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study.
LANCET HIV, 9 (8).
E534-E543.
Back, David, Marzolini, Catia, Hodge, Catherine, Marra, Fiona ORCID: 0000-0003-1326-1149, Boyle, Alison, Gibbons, Sara, Burger, David and Khoo, Saye
(2021)
COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (1).
pp. 212-213.
van der Wekken-Pas, Lena, Nassiwa, Sylvia, Malaba, Thokozule, Lamorde, Mohammed, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye, He, Nengjie, van Leeuwen, Liesbeth et al (show 3 more authors)
(2024)
Comparison of dolutegravir- and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV; a DolPHIN2 substudy.
AIDS (London, England).
Kintu, Kenneth, Malaba, Thokozile, Nakibuka, Jesca, Papamichael, Christiana, Colbers, Angela, Byrne, Kelly, Seden, Kay, Hodel, Eva Maria ORCID: 0000-0001-5821-1685, Chen, Tao ORCID: 0000-0002-5489-6450, Twimukye, Adelline et al (show 11 more authors)
(2020)
Dolutegravir versus efavirenz when starting HIV therapy in late pregnancy: a randomised controlled trial.
The Lancet HIV, 7 (5).
e332-e339.
Hodge, Daryl ORCID: 0000-0003-2288-7020, Marra, Fiona ORCID: 0000-0003-1326-1149, Marzolini, Catia, Boyle, Alison, Gibbons, Sara, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Back, David and Khoo, Saye
(2020)
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (12).
pp. 3417-3424.
Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Walker, A Sarah, Owen, Andrew ORCID: 0000-0002-9819-7651, Gibb, Diana M, Burger, David et al (show 2 more authors)
(2017)
Effect of diurnal variation, <i>CYP2B6</i> genotype and age on the pharmacokinetics of nevirapine in African children.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (1).
pp. 190-199.
Marra, Fiona ORCID: 0000-0003-1326-1149, Smolders, Elise J, El-Sherif, Omar, Boyle, Alison, Davidson, Katherine, Sommerville, Andrew J, Marzolini, Catia, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Gibbons, Sara et al (show 2 more authors)
(2021)
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
DRUGS IN R&D, 21 (1).
pp. 9-27.
Marzolini, Catia, Kuritzkes, Daniel R, Marra, Fiona, Boyle, Alison, Gibbons, Sara, Flexner, Charles, Pozniak, Anton, Boffito, Marta, Waters, Laura, Burger, David et al (show 2 more authors)
(2022)
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 112 (6).
pp. 1191-1200.
Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Owen, Andrew ORCID: 0000-0002-9819-7651, Walker, A Sarah, Gibb, DianaM et al (show 3 more authors)
(2016)
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 82 (1).
pp. 185-198.